"As stewards of the taxpayer, we need to know why CMS continues to pay for [Acthar] when Tricare and the nation's top insurance providers have severely restricted reimbursements for this drug," Sen. Tim Scott (R-SC) said in a letter to CMS.
Trending:
A senator found Medicare blowing hundreds of millions on a drug private insurers wouldn't touch — and nothing happened